Armored macrophage-targeted CAR-T cells reset and reprogram the tumor microenvironment and control metastatic cancer growth.
Scientists at the Icahn School of Medicine at Mount Sinai have unveiled a groundbreaking experimental...
Knowledge and News for the Global Fight Against Cancer.
Scientists at the Icahn School of Medicine at Mount Sinai have unveiled a groundbreaking experimental...
The landscape of gynecological oncology is facing a potential paradigm shift following a groundbreaking study...
Scientists at the Francis Crick Institute and Vividion Therapeutics have unveiled a revolutionary class of...
Researchers at Duke-NUS Medical School have identified a crucial molecular "switch" that dictates whether pancreatic...
In a landmark study that could redefine the future of preventive medicine, researchers at Stanford...
Researchers from the Salk Institute for Biological Studies, UNC Lineberger Comprehensive Cancer Center, and UC...
Dr. Vinay Prasad, a figure known for his outspoken critical analyses within the medical community...
WASHINGTON – Vinay Prasad, a prominent official at the Food and Drug Administration (FDA) whose...
Alnylam Pharmaceuticals, a leader in RNA interference (RNAi) therapeutics, has entered into a significant discovery...
The landscape of oncological care within the Department of Veterans Affairs (VA) is undergoing a...